BRISTOL-MYERS SQUIBB CO (BMY) Fundamental Analysis & Valuation
NYSE:BMY • US1101221083
Current stock price
59.2 USD
+1.53 (+2.65%)
At close:
59.11 USD
-0.09 (-0.15%)
Pre-Market:
This BMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BMY Profitability Analysis
1.1 Basic Checks
- BMY had positive earnings in the past year.
- In the past year BMY had a positive cash flow from operations.
- BMY had positive earnings in 4 of the past 5 years.
- Each year in the past 5 years BMY had a positive operating cash flow.
1.2 Ratios
- BMY's Return On Assets of 7.83% is amongst the best of the industry. BMY outperforms 88.54% of its industry peers.
- BMY's Return On Equity of 38.19% is amongst the best of the industry. BMY outperforms 96.88% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 19.52%, BMY belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for BMY is in line with the industry average of 13.06%.
- The last Return On Invested Capital (19.52%) for BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- With an excellent Profit Margin value of 14.64%, BMY belongs to the best of the industry, outperforming 88.02% of the companies in the same industry.
- BMY's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 35.82%, BMY belongs to the best of the industry, outperforming 96.35% of the companies in the same industry.
- BMY's Operating Margin has improved in the last couple of years.
- BMY's Gross Margin of 72.63% is fine compared to the rest of the industry. BMY outperforms 79.69% of its industry peers.
- BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. BMY Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BMY is creating value.
- Compared to 1 year ago, BMY has more shares outstanding
- BMY has less shares outstanding than it did 5 years ago.
- BMY has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.52 indicates that BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.52, BMY is doing good in the industry, outperforming 65.63% of the companies in the same industry.
- The Debt to FCF ratio of BMY is 3.51, which is a good value as it means it would take BMY, 3.51 years of fcf income to pay off all of its debts.
- BMY has a Debt to FCF ratio of 3.51. This is amongst the best in the industry. BMY outperforms 89.06% of its industry peers.
- A Debt/Equity ratio of 2.33 is on the high side and indicates that BMY has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 2.33, BMY is doing worse than 79.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.52 |
ROIC/WACC2.27
WACC8.61%
2.3 Liquidity
- BMY has a Current Ratio of 1.26. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- BMY has a worse Current ratio (1.26) than 77.60% of its industry peers.
- BMY has a Quick Ratio of 1.14. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- BMY has a worse Quick ratio (1.14) than 75.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. BMY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- The Earnings Per Share has been decreasing by -0.92% on average over the past years.
- Looking at the last year, BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
- Measured over the past years, BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.15% yearly.
- The Revenue is expected to decrease by -5.54% on average over the next years.
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. BMY Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 9.63, the valuation of BMY can be described as reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 92.19% of the companies listed in the same industry.
- BMY is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 9.35, the valuation of BMY can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 89.06% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.63 | ||
| Fwd PE | 9.35 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaply inside the industry as 92.71% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, BMY is valued cheaper than 92.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.39 | ||
| EV/EBITDA | 7.25 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMY does not grow enough to justify the current Price/Earnings ratio.
- BMY has an outstanding profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as BMY's earnings are expected to decrease with -4.05% in the coming years.
PEG (NY)3.24
PEG (5Y)N/A
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
5. BMY Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.30%, BMY is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.64, BMY pays a better dividend. On top of this BMY pays more dividend than 96.35% of the companies listed in the same industry.
- BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.3% |
5.2 History
- On average, the dividend of BMY grows each year by 6.51%, which is quite nice.
- BMY has paid a dividend for at least 10 years, which is a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
- BMY pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
- BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
BMY Fundamentals: All Metrics, Ratios and Statistics
59.2
+1.53 (+2.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change1.98%
Market Cap120.56B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target62.9 (6.25%)
Short Float %1.47%
Short Ratio2.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.3% |
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years4
Div Non Decr Years4
Ex-Date04-02 2026-04-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)1.39%
PT rev (3m)13.78%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)0.42%
EPS NY rev (1m)0%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)6.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.63 | ||
| Fwd PE | 9.35 | ||
| P/S | 2.5 | ||
| P/FCF | 9.39 | ||
| P/OCF | 8.52 | ||
| P/B | 6.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.25 |
EPS(TTM)6.15
EY10.39%
EPS(NY)6.33
Fwd EY10.7%
FCF(TTM)6.31
FCFY10.65%
OCF(TTM)6.95
OCFY11.74%
SpS23.67
BVpS9.07
TBVpS-10.99
PEG (NY)3.24
PEG (5Y)N/A
Graham Number35.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.52 |
F-Score7
WACC8.61%
ROIC/WACC2.27
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / BMY Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
How profitable is BRISTOL-MYERS SQUIBB CO (BMY) stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 8 / 10.
What is the valuation of BRISTOL-MYERS SQUIBB CO based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 9.63 and the Price/Book (PB) ratio is 6.53.
What is the earnings growth outlook for BRISTOL-MYERS SQUIBB CO?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 2.98% in the next year.